Therapy of bacterial vaginosis

Bacterial vaginosis (BV) is the commonest cause of abnormal vaginal discharge in women of childbearing age. The prevalence in the UK is between 10 and 15%. The principal symptom is an offensive fishy smell, accompanied by an increased vaginal discharge. When BV develops, the concentrations of many a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of antimicrobial chemotherapy 1998, Vol.41 (1), p.6-9
1. Verfasser: HAY, P. E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9
container_issue 1
container_start_page 6
container_title Journal of antimicrobial chemotherapy
container_volume 41
creator HAY, P. E
description Bacterial vaginosis (BV) is the commonest cause of abnormal vaginal discharge in women of childbearing age. The prevalence in the UK is between 10 and 15%. The principal symptom is an offensive fishy smell, accompanied by an increased vaginal discharge. When BV develops, the concentrations of many anaerobic or facultative anaerobic species, including Gardnerella vaginalis, Bacteroides spp. and Mycoplasma hominis, increase up to a thousand-fold, overwhelming the usually dominant lactobacilli. In the most severe forms of BV the lactobacilli disappear. The bacteria adhere to desquamated squamated squamous epithelial cells, giving them the appearance of 'clue cells'. The pH of vaginal fluid increases from the normal,
doi_str_mv 10.1093/jac/41.1.6
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79738693</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79738693</sourcerecordid><originalsourceid>FETCH-LOGICAL-c378t-f8538551d72c51397bc6c207fdf8da5a62efe4fb640f075c9f9a48b3fe227b9f3</originalsourceid><addsrcrecordid>eNqF0DtLA0EUBeBBlBijjb2SQiyETe6d95QSfEHAJtbD7OyMbthk40wi5N-7kiWt1SnOxykOIdcIEwTDpkvnpxwnOJEnZIhcQkHB4CkZAgNRKC7YObnIeQkAUkg9IAMjEIHhkNwuvkJym_24jePS-W1ItWvGP-6zXre5zpfkLLomh6s-R-Tj-Wkxey3m7y9vs8d54ZnS2yJqwbQQWCnqBTKjSi89BRWrqCsnnKQhBh5LySGCEt5E47guWQyUqtJENiL3h91Nar93IW_tqs4-NI1bh3aXrTKKaWnYvxAlV5widvDhAH1qc04h2k2qVy7tLYL9e812r1mOFq3s8E2_uitXoTrS_qauv-t7l71rYnJrX-cjo8i5Yor9AtyOctc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16474211</pqid></control><display><type>article</type><title>Therapy of bacterial vaginosis</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>HAY, P. E</creator><creatorcontrib>HAY, P. E</creatorcontrib><description>Bacterial vaginosis (BV) is the commonest cause of abnormal vaginal discharge in women of childbearing age. The prevalence in the UK is between 10 and 15%. The principal symptom is an offensive fishy smell, accompanied by an increased vaginal discharge. When BV develops, the concentrations of many anaerobic or facultative anaerobic species, including Gardnerella vaginalis, Bacteroides spp. and Mycoplasma hominis, increase up to a thousand-fold, overwhelming the usually dominant lactobacilli. In the most severe forms of BV the lactobacilli disappear. The bacteria adhere to desquamated squamated squamous epithelial cells, giving them the appearance of 'clue cells'. The pH of vaginal fluid increases from the normal, &lt;4.5, to as high as 7.0. The term bacterial vaginosis was adopted in 1983, the word 'bacterial' to indicate that many bacterial species are present, and the suffix -'osis' because inflammation is absent. Some clinicians use alternative terms such as anaerobic vaginosis, non-specific vaginosis or even 'gardnerella'.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/41.1.6</identifier><identifier>PMID: 9511031</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antifungal agents ; Antitrichomonal Agents - administration &amp; dosage ; Bacteroides ; Bacteroides Infections - therapy ; Biological and medical sciences ; Clindamycin - administration &amp; dosage ; Drug Therapy, Combination - therapeutic use ; Erythromycin - administration &amp; dosage ; Female ; Gardnerella vaginalis ; Humans ; Medical sciences ; Metronidazole - administration &amp; dosage ; Mycoplasma hominis ; Mycoplasma Infections - therapy ; Pharmacology. Drug treatments ; Pregnancy ; Pregnancy Complications ; Sexually Transmitted Diseases - drug therapy ; Vaginosis, Bacterial - drug therapy ; Vaginosis, Bacterial - therapy</subject><ispartof>Journal of antimicrobial chemotherapy, 1998, Vol.41 (1), p.6-9</ispartof><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c378t-f8538551d72c51397bc6c207fdf8da5a62efe4fb640f075c9f9a48b3fe227b9f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4023,27922,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2144737$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9511031$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HAY, P. E</creatorcontrib><title>Therapy of bacterial vaginosis</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>Bacterial vaginosis (BV) is the commonest cause of abnormal vaginal discharge in women of childbearing age. The prevalence in the UK is between 10 and 15%. The principal symptom is an offensive fishy smell, accompanied by an increased vaginal discharge. When BV develops, the concentrations of many anaerobic or facultative anaerobic species, including Gardnerella vaginalis, Bacteroides spp. and Mycoplasma hominis, increase up to a thousand-fold, overwhelming the usually dominant lactobacilli. In the most severe forms of BV the lactobacilli disappear. The bacteria adhere to desquamated squamated squamous epithelial cells, giving them the appearance of 'clue cells'. The pH of vaginal fluid increases from the normal, &lt;4.5, to as high as 7.0. The term bacterial vaginosis was adopted in 1983, the word 'bacterial' to indicate that many bacterial species are present, and the suffix -'osis' because inflammation is absent. Some clinicians use alternative terms such as anaerobic vaginosis, non-specific vaginosis or even 'gardnerella'.</description><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antifungal agents</subject><subject>Antitrichomonal Agents - administration &amp; dosage</subject><subject>Bacteroides</subject><subject>Bacteroides Infections - therapy</subject><subject>Biological and medical sciences</subject><subject>Clindamycin - administration &amp; dosage</subject><subject>Drug Therapy, Combination - therapeutic use</subject><subject>Erythromycin - administration &amp; dosage</subject><subject>Female</subject><subject>Gardnerella vaginalis</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Metronidazole - administration &amp; dosage</subject><subject>Mycoplasma hominis</subject><subject>Mycoplasma Infections - therapy</subject><subject>Pharmacology. Drug treatments</subject><subject>Pregnancy</subject><subject>Pregnancy Complications</subject><subject>Sexually Transmitted Diseases - drug therapy</subject><subject>Vaginosis, Bacterial - drug therapy</subject><subject>Vaginosis, Bacterial - therapy</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0DtLA0EUBeBBlBijjb2SQiyETe6d95QSfEHAJtbD7OyMbthk40wi5N-7kiWt1SnOxykOIdcIEwTDpkvnpxwnOJEnZIhcQkHB4CkZAgNRKC7YObnIeQkAUkg9IAMjEIHhkNwuvkJym_24jePS-W1ItWvGP-6zXre5zpfkLLomh6s-R-Tj-Wkxey3m7y9vs8d54ZnS2yJqwbQQWCnqBTKjSi89BRWrqCsnnKQhBh5LySGCEt5E47guWQyUqtJENiL3h91Nar93IW_tqs4-NI1bh3aXrTKKaWnYvxAlV5widvDhAH1qc04h2k2qVy7tLYL9e812r1mOFq3s8E2_uitXoTrS_qauv-t7l71rYnJrX-cjo8i5Yor9AtyOctc</recordid><startdate>1998</startdate><enddate>1998</enddate><creator>HAY, P. E</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>1998</creationdate><title>Therapy of bacterial vaginosis</title><author>HAY, P. E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c378t-f8538551d72c51397bc6c207fdf8da5a62efe4fb640f075c9f9a48b3fe227b9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antifungal agents</topic><topic>Antitrichomonal Agents - administration &amp; dosage</topic><topic>Bacteroides</topic><topic>Bacteroides Infections - therapy</topic><topic>Biological and medical sciences</topic><topic>Clindamycin - administration &amp; dosage</topic><topic>Drug Therapy, Combination - therapeutic use</topic><topic>Erythromycin - administration &amp; dosage</topic><topic>Female</topic><topic>Gardnerella vaginalis</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Metronidazole - administration &amp; dosage</topic><topic>Mycoplasma hominis</topic><topic>Mycoplasma Infections - therapy</topic><topic>Pharmacology. Drug treatments</topic><topic>Pregnancy</topic><topic>Pregnancy Complications</topic><topic>Sexually Transmitted Diseases - drug therapy</topic><topic>Vaginosis, Bacterial - drug therapy</topic><topic>Vaginosis, Bacterial - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HAY, P. E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HAY, P. E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapy of bacterial vaginosis</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>1998</date><risdate>1998</risdate><volume>41</volume><issue>1</issue><spage>6</spage><epage>9</epage><pages>6-9</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><abstract>Bacterial vaginosis (BV) is the commonest cause of abnormal vaginal discharge in women of childbearing age. The prevalence in the UK is between 10 and 15%. The principal symptom is an offensive fishy smell, accompanied by an increased vaginal discharge. When BV develops, the concentrations of many anaerobic or facultative anaerobic species, including Gardnerella vaginalis, Bacteroides spp. and Mycoplasma hominis, increase up to a thousand-fold, overwhelming the usually dominant lactobacilli. In the most severe forms of BV the lactobacilli disappear. The bacteria adhere to desquamated squamated squamous epithelial cells, giving them the appearance of 'clue cells'. The pH of vaginal fluid increases from the normal, &lt;4.5, to as high as 7.0. The term bacterial vaginosis was adopted in 1983, the word 'bacterial' to indicate that many bacterial species are present, and the suffix -'osis' because inflammation is absent. Some clinicians use alternative terms such as anaerobic vaginosis, non-specific vaginosis or even 'gardnerella'.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>9511031</pmid><doi>10.1093/jac/41.1.6</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 1998, Vol.41 (1), p.6-9
issn 0305-7453
1460-2091
language eng
recordid cdi_proquest_miscellaneous_79738693
source MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry
subjects Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antifungal agents
Antitrichomonal Agents - administration & dosage
Bacteroides
Bacteroides Infections - therapy
Biological and medical sciences
Clindamycin - administration & dosage
Drug Therapy, Combination - therapeutic use
Erythromycin - administration & dosage
Female
Gardnerella vaginalis
Humans
Medical sciences
Metronidazole - administration & dosage
Mycoplasma hominis
Mycoplasma Infections - therapy
Pharmacology. Drug treatments
Pregnancy
Pregnancy Complications
Sexually Transmitted Diseases - drug therapy
Vaginosis, Bacterial - drug therapy
Vaginosis, Bacterial - therapy
title Therapy of bacterial vaginosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T05%3A17%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapy%20of%20bacterial%20vaginosis&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=HAY,%20P.%20E&rft.date=1998&rft.volume=41&rft.issue=1&rft.spage=6&rft.epage=9&rft.pages=6-9&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/41.1.6&rft_dat=%3Cproquest_cross%3E79738693%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16474211&rft_id=info:pmid/9511031&rfr_iscdi=true